Juliette O. Thariat
Experienced in Spasmodic Dysphonia

Juliette O. Thariat

Caen, FR 
Clinical Trials:Currently Recruiting for 2 Trials
Experienced in Spasmodic Dysphonia
Caen, FR 
OverviewLocationsClinical Research

Overview

Juliette Thariat practices in Caen, France. Ms. Thariat is rated as an Experienced expert by MediFind in the treatment of Spasmodic Dysphonia. Her top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Adult Soft Tissue Sarcoma, Salivary Gland Tumors, Tissue Biopsy, and Mastectomy.

Her clinical research consists of co-authoring 534 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Spasmodic Dysphonia.

Gender
Female

Locations

Caen, France
Other Locations
Francois, France
France
Ollioules, 83189, France
Rouen, France
Herouville, France
Nice, France
Paris, France
Sophia Antipolis, France
9, Avenue Charles De GAULLE, Boulogne-billancourt, 92100, France
Boulevard Jacques Monod, Rene, 44805, France
Lacassagne, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Health Effects of CArdiac FluoRoscopy and MOderN RadIotherapy in PediatriCs - Radiotherapy (HARMONIC-RT)
Health Effects of CArdiac FluoRoscopy and MOderN RadIotherapy in PediatriCs - Radiotherapy (HARMONIC-RT)
Enrollment Status: Recruiting
Publish Date: April 04, 2025
Intervention Type: Other
Circulating Immunes Cells, Cytokines and Brain Radiotherapy
Circulating Immunes Cells, Cytokines and Brain Radiotherapy
Enrollment Status: Recruiting
Publish Date: December 11, 2024
Intervention Type: Other
Study Phase: Not Applicable
Cohorte Non Interventionnelle Ambispective Nationale Multicentrique de Patients Suivis Pour Cancer et infectés Par le SARS-CoV-2
Cohorte Non Interventionnelle Ambispective Nationale Multicentrique de Patients Suivis Pour Cancer et infectés Par le SARS-CoV-2
Enrollment Status: Completed
Publish Date: April 04, 2022
A Randomized, Double-blind, Placebo-controlled Phase III Study, to Evaluate the Efficacy of Afatinib (BIBW2992) in Maintenance Therapy After Post- Operative Radio-chemotherapy in Squamous-cell Carcinoma of the Head and Neck: GORTEC 2010-02
A Randomized, Double-blind, Placebo-controlled Phase III Study, to Evaluate the Efficacy of Afatinib (BIBW2992) in Maintenance Therapy After Post- Operative Radio-chemotherapy in Squamous-cell Carcinoma of the Head and Neck: GORTEC 2010-02
Enrollment Status: Completed
Publish Date: June 01, 2021
Intervention Type: Drug
Study Drug: Afatinib
Study Phase: Phase 3
Randomised Multicentric Phase III Study Comparing Observation Versus Post-surgery Radiotherapy After Complete Exeresis With Margins Greater Than or Equal to 1 cm in Soft Tissues Members Sarcoma.
Randomised Multicentric Phase III Study Comparing Observation Versus Post-surgery Radiotherapy After Complete Exeresis With Margins Greater Than or Equal to 1 cm in Soft Tissues Members Sarcoma.
Enrollment Status: Terminated
Publish Date: August 22, 2018
Intervention Type: Other, Radiation
Study Phase: Phase 3
View 3 Less Clinical Trials

534 Total Publications

Flap sparing in postoperative radiotherapy versus standard flap-agnostic radiotherapy of oral cavity cancers (OPTIFLAP): protocol for a de-escalation, randomised, non-inferiority, phase III trial.
Flap sparing in postoperative radiotherapy versus standard flap-agnostic radiotherapy of oral cavity cancers (OPTIFLAP): protocol for a de-escalation, randomised, non-inferiority, phase III trial.
Journal: BMJ open
Published: September 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Thariat's expertise for a condition
ConditionClose
    View All 7 Distinguished Conditions
    View All 18 Advanced Conditions
    View All 87 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile